SkinHealth Systems (SKIN) Fundamentals 2026 — Revenue Analysis | SniperIQ
SkinHealth Systems (SKIN) is a US-listed Healthcare company in Medical - Devices with a market capitalization of
01M, trading at $0.78 on the NASDAQ. This SniperIQ fundamentals page covers SkinHealth Systems's valuation, profitability (net margin -2.0%), revenue (
01M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market Cap
01M
Net Margin-2.0%
Revenue (FY25)
01M
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is SkinHealth Systems's market cap?
SkinHealth Systems (SKIN) has a market capitalization of approximately
01M, trading at $0.78 on the NASDAQ. Market cap moves with the live share price.
What is SkinHealth Systems's P/E ratio?
SkinHealth Systems's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is SkinHealth Systems?
SkinHealth Systems runs a net profit margin of -2.0%, a gross margin of 64.9%, and an operating margin of -3.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does SkinHealth Systems generate?
SkinHealth Systems reported revenue of
01M for fiscal year 2025, with net income of -
0M and earnings per share (EPS) of -0.08. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does SkinHealth Systems pay a dividend?
SkinHealth Systems does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is SkinHealth Systems financially healthy?
SkinHealth Systems carries a debt-to-equity ratio of 6.65x and a current ratio of 1.79x, with a market beta of 1.08. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is SkinHealth Systems a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For SkinHealth Systems (SKIN) the key facts are: market cap
01M, revenue
01M, 52-week range 0.551-2.69. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track SkinHealth Systems's full fundamentals live
Get SkinHealth Systems's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.